Rheumatology and Pulmonary Clinic

Beckley, West Virginia 25801-2805

3 studies enrolling now · 15 studies all time

What they study most

Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, Psoriatic, Arthritis, Rheumatoid, Interstitial Lung Diseases, Lupus Erythematosus, Systemic, Osteoarthritis, Hip, Osteoarthritis, Knee, Rheumatoid Arthritis, Sjogren's Syndrome, Sjögren's Syndrome, Sjögren's Syndrome (SS), Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases

Studies at this site

• A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
• A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis — Recruiting now
• A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) — Recruiting now
• Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity — Running, not enrolling
• A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State — Running, not enrolling
• A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus — Completed
• Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor — Completed
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
• Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. — Completed
• A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis — Completed
• A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections — Stopped early
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). — Completed
• Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis — Stopped early